↓ Skip to main content

Worldwide access to treatment for end-stage kidney disease: a systematic review

Overview of attention for article published in The Lancet, May 2015
Altmetric Badge

About this Attention Score

  • In the top 5% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (99th percentile)
  • High Attention Score compared to outputs of the same age and source (97th percentile)

Mentioned by

news
25 news outlets
blogs
4 blogs
twitter
92 tweeters
facebook
7 Facebook pages
wikipedia
1 Wikipedia page
googleplus
2 Google+ users

Citations

dimensions_citation
927 Dimensions

Readers on

mendeley
976 Mendeley
citeulike
1 CiteULike
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Worldwide access to treatment for end-stage kidney disease: a systematic review
Published in
The Lancet, May 2015
DOI 10.1016/s0140-6736(14)61601-9
Pubmed ID
Authors

Thaminda Liyanage, Toshiharu Ninomiya, Vivekanand Jha, Bruce Neal, Halle Marie Patrice, Ikechi Okpechi, Ming-hui Zhao, Jicheng Lv, Amit X Garg, John Knight, Anthony Rodgers, Martin Gallagher, Sradha Kotwal, Alan Cass, Vlado Perkovic

Abstract

End-stage kidney disease is a leading cause of morbidity and mortality worldwide. Prevalence of the disease and worldwide use of renal replacement therapy (RRT) are expected to rise sharply in the next decade. We aimed to quantify estimates of this burden.

Twitter Demographics

The data shown below were collected from the profiles of 92 tweeters who shared this research output. Click here to find out more about how the information was compiled.

Mendeley readers

The data shown below were compiled from readership statistics for 976 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Malaysia 2 <1%
Australia 2 <1%
Japan 2 <1%
Norway 1 <1%
India 1 <1%
Guatemala 1 <1%
South Africa 1 <1%
Unknown 966 99%

Demographic breakdown

Readers by professional status Count As %
Student > Master 163 17%
Student > Bachelor 121 12%
Researcher 113 12%
Student > Ph. D. Student 99 10%
Student > Postgraduate 96 10%
Other 179 18%
Unknown 205 21%
Readers by discipline Count As %
Medicine and Dentistry 393 40%
Nursing and Health Professions 107 11%
Biochemistry, Genetics and Molecular Biology 37 4%
Engineering 35 4%
Agricultural and Biological Sciences 33 3%
Other 139 14%
Unknown 232 24%

Attention Score in Context

This research output has an Altmetric Attention Score of 267. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 25 March 2021.
All research outputs
#83,807
of 19,495,308 outputs
Outputs from The Lancet
#1,368
of 37,869 outputs
Outputs of similar age
#1,168
of 227,956 outputs
Outputs of similar age from The Lancet
#15
of 551 outputs
Altmetric has tracked 19,495,308 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 99th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 37,869 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 62.4. This one has done particularly well, scoring higher than 96% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 227,956 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 99% of its contemporaries.
We're also able to compare this research output to 551 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 97% of its contemporaries.